Filing Details
- Accession Number:
- 0001181431-13-052838
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-07 13:59:49
- Reporting Period:
- 2013-10-04
- Filing Date:
- 2013-10-07
- Accepted Time:
- 2013-10-07 13:59:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238362 | John Mendlein | C/O Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-10-04 | 16,667 | $6.00 | 156,774 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
